We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current ACL market cap is 496.51M. The company's latest EPS is AUD 0.1779 and P/E is 13.83.
| Year End 30 June 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 519.47M | 0 | 644.67M | 997.17M | 704.76M |
| Operating Income | 47.31M | 0 | 108.55M | 266.6M | 61.99M |
| Net Income | 41.26M | 0 | 60.37M | 178.24M | 35.9M |
| Year End 30 June 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 366.05M | 406.7M | 484.1M | 628.04M | 578.91M |
| Total Liabilities | 297.07M | 359.6M | 402.19M | 395.49M | 406.24M |
| Total Equity | 68.99M | 47.1M | 81.91M | 232.56M | 172.67M |
| Year End 30 June 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | 101.74M | N/A | 153.86M | 284.09M | 143.68M |
| Investing | -9.96M | N/A | -6.08M | -72.04M | -12.18M |
| Financing | -60.92M | N/A | -147.37M | -220.91M | -137.88M |
| Market Cap | 496.51M |
| Price to Earnings Ratio | 13.83 |
| Price to Sales Ratio | 0.7 |
| Price to Cash Ratio | 24.87 |
| Price to Book Ratio | 2.88 |
| Dividend Yield | - |
| Shares Outstanding | 201.83M |
| Average Volume (1 week) | 297.26k |
| Average Volume (1 Month) | 316.49k |
| 52 Week Change | -32.04% |
| 52 Week High | 3.69 |
| 52 Week Low | 2.26 |
| Spread (Intraday) | 0.05 (2%) |
| Company Name | Australian Clinical Labs Limited |
| Address |
1868-1892 dandenong road melbourne, victoria 3168 |
| Website | https://clinicallabs.com.au/offer |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
